Oligonucleotide array comparative genomic hybridization profiling of neuroblastoma tumours

Cancer Genomics and Proteomics

Volumn 3, Issue 3-4, 2006, Pages 245-252

  Scaruffi, Paola ^a   Moretti, Stefano ^a   Coco, Simona ^a   Mazzocco, Katia ^b   Defferrari, Raffaella ^b   Albino, Domenico ^b   Bonassi, Stefano ^a   Tonini, Gian Paolo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Italian Neuroblastoma Foundation   (Italy)

Author keywords

CGH; Chromosome 1p; Microarray; MYCN; Neuroblastoma

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; MOLECULAR MARKER; OLIGONUCLEOTIDE; TUMOR MARKER;

ARTICLE; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; GENOME; HUMAN; HUMAN TISSUE; MYCN GENE; NEUROBLASTOMA CELL; OLIGONUCLEOTIDE PROBE; ONCOGENE; TISSUE MICROARRAY;

EID: 33746614156     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Brodeur GM: Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216, 2003.
2. Westermann F and Schwab M: Genetic parameters of neuroblastomas. Cancer Lett 184(2): 127-147, 2002.
3. Tonini GP and Romani M: Genetic and epigenetic alterations in neuroblastoma. Cancer Lett 197(1-2): 69-73, 2003.
4. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM and Maris JM: Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18: 4948-4957, 1999.
5. Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC and Brodeur GM: Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J Clin Oncol 18(9): 1888-1889, 2000.
6. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J and Van Roy N: Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 340(25): 1954-1961, 1999.
7. Maris JM and Matthay KK: Molecular biology of neuroblastoma. J Clin Oncol 17(7): 2264-2279, 1999.
8. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258(5083): 818-821, 1992.
9. Van Gele M, Van Roy N, Jauch A, Laureys G, Benoit Y, Schelfhout V, De Potter CR, Brock P, Uyttebroeck A, Sciot R, Schuuring E, Versteeg R and Speleman F: Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis. Eur J Cancer 33(12): 1979-1982, 1997.
10. Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A and Speleman F: Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 23(2): 141-152, 1998.
11. Brinkschmidt C, Poremba C, Christiansen H, Simon R, Schafer KL, Terpe HJ, Lampert F, Boecker W and Dockhorn-Dworniczak B: Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas. Br J Cancer 77(12): 2223-2229, 1998.
12. Cunsolo CL, Bicocchi MP, Petti AR and Tonini GP: Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status. Br J Cancer 83(10): 1295-1300, 2000.
13. Breen CJ, O'Meara A, McDermott M, Mullarkey M and Stallings RL: Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization. Cancer Genet Cytogenet 120(1): 44-49, 2000.
14. Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG and Plantaz D: Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol 36(1): 5-10, 2001
15. Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Benard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, Caron H, Matthay KK, Feuerstein BG and Speleman F: Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification. Int J Cancer 97(5): 680-686, 2001.
16. Brodeur GM, Azar C, Brother M, Hiemstra J, Kaufman B, Marshall H, Moley J, Nakagawara A, Saylors R, Scavarda N et al: Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer 70: 1685-1694, 1992.
17. Brinkschmidt C, Christiansen H, Terpe HJ, Simon R, Boecker W, Lampert F and Stoerkel S: Comparative genomic hybridization (CGH) analysis of neuroblastomas - an important methodological approach in paediatric tumour pathology. J Pathol 181(4): 394-400, 1997.
18. Cohen N, Betts DR, Trakhtenbrot L, Niggli FK, Amariglio N, Brok-Simoni F, Rechavi G and Meitar D: Detection of unidentified chromosome abnormalities in human neuroblastoma by spectral karyotyping (SKY). Genes Chromosomes Cancer 31(3): 201-208, 2001
19. Schleiermacher G, Janoueix-Lerosey I, Combaret V, Derre J, Couturier J, Aurias A and Delattre O: Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma. Cancer Genet Cytogenet 141(1): 32-42, 2003.
20. Parente F, Gaudray P, Carle GF and Turc-Carel C: Experimental assessment of the detection limit of genomic amplification by comparative genomic hybridization CGH. Cytogenet Cell Genet 78(1): 65-68, 1997.
21. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T and Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20(4): 399-407, 1997.
22. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW and Albertson DG: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20(2): 207-211,1998.
23. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B, Kimura K, Law S, Myambo K, Palmer J, Ylstra B, Yue JP, Gray JW, Jain AN, Pinkel D and Albertson DG: Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29(3): 263-264, 2001.
24. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D and Brown PO: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 23(1): 41-46, 1999.
25. Chen QR, Bilke S, Wei JS, Whiteford CC, Cenacchi N, Krasnoselsky AL, Greer BT, Son CG, Westermann F, Berthold F, Schwab M, Catchpoole D and Khan J: cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma. BMC Genomics 5(1): 70, 2004.
26. Bilke S, Chen QR, Whiteford CC and Khan J: Detection of low level genomic alterations by comparative genomic hybridization based on cDNA micro-arrays. Bioinformatics 21(7): 1138-1145, 2005.
27. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL and Brown PO: Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 99(20): 12963-12968, 2002.
28. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP and Kallioniemi A: Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res 62(21): 6240-6245, 2002.
29. Selzer RR, Richmond TA, Pofahl NJ, Green RD, Eis PS, Nair P, Brothman AR and Stallings RL: Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligo nucleotide array CGH. Genes Chromosomes Cancer 44(3): 305-319, 2005.
30. Scaruffi P, Valent A, Schramm A, Astrahantseff K, Eggert A and Tonini GP: Application of microarray-based technology to neuroblastoma. Cancer Lett 228(1-2): 13-20, 2005.
31. Beheshti B, Braude I, Marrano P, Thorner P, Zielenska M and Squire JA: Chromosomal localization of DNA amplifications in neuroblastoma tumors using cDNA microarray comparative genomic hybridization. Neoplasia 5(1): 53-62, 2003.
32. De Preter K, Pattyn F, Berx G, Strumane K, Menten B, Van Roy F, De Paepe A, Speleman F and Vandesompele J: Combined subtractive cDNA cloning and array CGH: an efficient approach for identification of overexpressed genes in DNA amplicons. BMC Genomics 5(1): 11, 2004.
33. Mosse YP, Greshock J, Margolin A, Naylor T, Cole K, Khazi D, Hii G, Winter C, Shahzad S, Asziz MU, Biegel JA, Weber BL and Maris JM: High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43(4): 390-403, 2005.
34. Scaruffi P, Parodi S, Mazzocco K, Defferrari R, Fontana V, Bonassi S and Tonini GP: Detection of MYCN amplification and chromosome 1p36 loss in neuroblastoma by cDNA microarray comparative genomic hybridization. Mol Diagn 8(2): 93-100, 2004.
35. Ambros PF and Ambros IM: SIOP Europe Neuroblastoma Pathology, Biology, and Bone Marrow Group. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 37(6): 492-504, 2001.
36. Shimada H: The International Neuroblastoma Pathology Classification. Pathologica 95(5): 240-241, 2003.
37. Ambros IM, Benard J, Boavida M et al: Quality assessment of genetic markers used for therapy stratification. J Clin Oncol 21: 2077-2084, 2003.
38. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning. A Laboratory Manual. Second edition. Cold Spring Harbor Laboratory Press, 1989.
39. Smyth GK and Speed TP: Normalization of cDNA microarray data. Methods 31(4): 265-273, 2003.
40. Smyth GK, Michaud J and Scott HS: Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21(9): 2067-2075, 2005.
41. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JYH and Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: 80, 2004.
42. Dudoit S, Yang YH, Callow MJ and Speed TP: Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistics Sinica 12: 111-140, 2002.
43. Yang YH, Dudoit S, Luu P and Speed TP: Normalization for cDNA microarray data. In: Microarrays: Optical Technologies and Informatics. Bittner ML, Chen Y, Dorsel AN, Dougherty ER (eds.). Proceedings of SPIE, pp. 141-152, 2001.
44. Smyth GK: Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W (eds.). Springer, New York, pp. 397-420, 2005.
45. Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Perez C, Haase GM and Matthay KK: Biologic factors determine prognosis in infants with stage IV neuroblastoma: a prospective Children's Cancer Group study. J Clin Oncol 18(6): 1260-1268, 2000.
46. Wimmer K, Zhu XX, Lamb BJ, Kuick R, Ambros PF, Kovar H, Thoraval D, Motyka S, Alberts JR and Hanash SM: Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene 18(1): 233-238, 1999.
47. Goodabout R and Squire J: Amplification of a DEAD box protein gene in retinoblastoma cell lines. Proc Natl Acad Sci USA 90: 7578-7582, 1993.
48. Squire JA, Thorner PS, Weitzman S, Maggi JD, Dirks P, Doyle J, Hale M and Goodabout R: Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene 10: 1417-1422, 1995.
49. Manohar CF, Salwen HR, Brodeur GM and Conn SL: Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes Chromosomes Cancer 14: 196-203, 1995.
50. Amler LC, Schurmann J and Schwab M: The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma. Genes Chromosomes Cancer 15: 134-137, 1996.
51. George RE, Kenyon R, McGuckin AG, Kohl N, Kogner P, Christiansen H, Pearson AD and Lunec J: Analysis of candidate gene co-amplification with MYCN in neuroblastoma. Eur J Cancer 33: 2037-2042, 1997.
52. Pandita A, Goodabout R, Zielenska M, Thorner P, Bayani J and Squire JA: Relational mapping of MYCN and DDXI in band 2p24 and analysis of amplicon arrays in double minute chromosomes and homogeneously staining regions by use of free chromatin FISH. Genes Chromosomes Cancer 20: 243-252, 1997.
53. De Preter K, Speleman F, Combaret V, Lunec J, Laureys G, Eussen BH, Francott N, Board J, Pearson AD, De Paepe A, Van Roy N and Vandesompele J: Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 15: 159-166, 2002.
54. Fong CT, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE and Brodeur GM: Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci USA 86(10): 3753-3757, 1989.
55. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT and Brodeur GM: Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 55(20): 4664-4669, 1995.
56. Caron H, van Sluis P, de Kraker J, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA and Versteeg R: Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 334(4): 225-230, 1996.
57. Martinsson T, Sjoberg RM, Hedborg F and Kogner P: Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55(23): 5681-5686, 1995.
58. Takeda O, Homma C, Maseki N, Sakurai M, Kanda N, Schwab M, Nakamura Y and Kaneko Y: There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma. Genes Chromosomes Cancer 10(1): 30-39, 1994.
59. Iolascon A, Lo Cunsolo C, Giordani L, Cusano R, Mazzocco K, Boumgartner M, Ghisellini P, Faienza MF, Boni L, De Bernardi B, Conte M, Romeo G and Tonini GP: Interstitial and large chromosome 1p deletion occurs in localized and disseminated neuroblastomas and predicts an unfavourable outcome. Cancer Lett 130(1-2): 83-92, 1998.
60. Lucito R, Healy J, Alexander J, Reiner A, Esposito D, Chi M, Rodgers L, Brady A, Sebat J, Troge J, West JA, Rostan S, Nguyen KC, Powers S, Ye KQ, Olshen A, Venkatraman E, Norton L and Wigler M: Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res 13(10): 2291-2305, 2003.
61. Bignell GR, Huang J, Greshock J, Watt S, Butler A, West S, Grigorova M, Jones KW, Wei W, Stratton MR, Futreal PA, Weber B, Shapero MH and Wooster R: High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Res 14(2): 287-295, 2004.
62. Zhao X, Li C, Paez JG, Chin K, Janne PA, Chen TH, Girard L, Minna J, Christiani D, Leo C, Gray JW, Sellers WR and Meyerson M: An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 64(9): 3060-3071, 2004.
63. Lucito R, Nakimura M, West JA, Han Y, Chin K, Jensen K, McCombie R, Gray JW and Wigler M: Genetic analysis using genomic representations. Proc Natl Acad Sci USA 95(8): 4487-4492, 1998.
64. Brennan C, Zhang Y, Leo C, Feng B, Cauwels C, Aguirre AJ, Kim M, Protopopov A and Chin L: High-resolution global profiling of genomic alterations with long oligonucleotide microarray. Cancer Res 64(14): 4744-4748, 2004.